159 related articles for article (PubMed ID: 31220042)
21. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
22. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
23. Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon.
Barreto JG; Guimarães Lde S; Leão MR; Ferreira DV; Lima RA; Salgado CG
Lepr Rev; 2011 Dec; 82(4):358-70. PubMed ID: 22439276
[TBL] [Abstract][Full Text] [Related]
24. Immunological response to homologous and heterologous phenolic glycolipid antigens in tuberculosis and leprosy.
Torgal-Garcia J; Papa F; David HL
Acta Leprol; 1989; 7 Suppl 1():102-6. PubMed ID: 2503962
[TBL] [Abstract][Full Text] [Related]
25. Use of the anti-PGL-I antibody ELISA and the Mitsuda reaction in early diagnosis of leprosy.
Saad MH; Medeiros MA; Gallo ME; Fonseca LS
Braz J Med Biol Res; 1991; 24(8):801-5. PubMed ID: 1797269
[TBL] [Abstract][Full Text] [Related]
26. IgM immunoglobulins reacting with the phenolic glycolipid-1 antigen from Mycobacterium leprae in sera of leprosy patients and their contacts.
Saad MH; Medeiros MA; Gallo ME; Gontijo PP; Fonseca LS
Mem Inst Oswaldo Cruz; 1990; 85(2):191-4. PubMed ID: 2087157
[TBL] [Abstract][Full Text] [Related]
27. Comparison of synthetic antigens for detecting antibodies to phenolic glycolipid I in patients with leprosy and their household contacts.
Chanteau S; Cartel JL; Roux J; Plichart R; Bach MA
J Infect Dis; 1988 Apr; 157(4):770-6. PubMed ID: 3346568
[TBL] [Abstract][Full Text] [Related]
28. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
Britton WJ; Garsia RJ; Basten A
Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
[TBL] [Abstract][Full Text] [Related]
29. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
[TBL] [Abstract][Full Text] [Related]
30. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.
Carvalho AP; da Conceição Oliveira Coelho Fabri A; Corrêa Oliveira R; Lana FC
BMC Infect Dis; 2015 May; 15():219. PubMed ID: 26024906
[TBL] [Abstract][Full Text] [Related]
32. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
[TBL] [Abstract][Full Text] [Related]
33. Salivary anti-PGL-1 IgM may indicate active transmission of Mycobacterium leprae among young people under 16 years of age.
Macedo AC; Cunha JE; Yaochite JNU; Tavares CM; Nagao-Dias AT
Braz J Infect Dis; 2017; 21(5):557-561. PubMed ID: 28602616
[TBL] [Abstract][Full Text] [Related]
34. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
35. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
Lefford MJ; Hunegnaw M; Siwik E
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
[TBL] [Abstract][Full Text] [Related]
36. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.
Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM
Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070
[TBL] [Abstract][Full Text] [Related]
37. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
Cartel JL; Chanteau S; Boutin JP; Plichart R; Richez P; Roux JF; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
[TBL] [Abstract][Full Text] [Related]
38. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
[TBL] [Abstract][Full Text] [Related]
39. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
40. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR
Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
